-+ 0.00%
-+ 0.00%
-+ 0.00%

Yestar Healthcare expects at least RMB 450,000 net loss for H1 2026

PUBT·08/17/2026 10:40:00
Listen to the news
Yestar Healthcare expects at least RMB 450,000 net loss for H1 2026
  • Yestar flagged a swing to an unaudited consolidated net loss of at least RMB 450,000 for H1 2026.
  • That compares with an unaudited consolidated net profit of about RMB 11.1 million in H1 2025.
  • Revenue in the medical products segment fell amid pricing pressure from China’s national and provincial drug bulk-purchase schemes.
  • Distributors shifted to buying in bulk directly from the National Healthcare Security Administration at lower costs.
  • Interim results are expected on Aug. 28, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yestar Healthcare Holdings Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260817-12287137), on August 17, 2026, and is solely responsible for the information contained therein.